GLP-1 agonists should not be prescribed for type 1 diabetes, during pregnancy, or with breastfeeding
It is vitally important to validate that these debilitating symptoms are not simply in your head, nor are they a sign of weakness
Semaglutide, being the only injectable and orally administered glucagon-like peptide-1 receptor agonist (GLP-1RA), has garnered significant attention (Nauck and Meier, 2019b)
Similarly, without these implications, 40% plan to start and stop based on needs, compared to 22% with no side effects
Sound Medical combines obesity medicine, hormone optimization, metabolic health, advanced diagnostics, and ongoing clinical support into one comprehensive care experience, because lasting results require more than a prescription
Book Your Free GLP-1 Weight Loss Consultation in Spain Ready to start your transformation